[Managing comorbidities of inflammatory rheumatic diseases]
- PMID: 21553073
- DOI: 10.1007/s00108-010-2769-0
[Managing comorbidities of inflammatory rheumatic diseases]
Abstract
Patients with inflammatory rheumatic diseases often suffer from considerable comorbidities that can arise due to the chronic systemic inflammatory activity of the rheumatic disease itself, disorders of immune defense, or as a result of antirheumatic treatment; they can also occur independently. For example, almost 50% of patients with rheumatoid arthritis already exhibit two further chronic diseases at the time of initial manifestation. With regard to the elevated mortality observed in patients with rheumatism, particularly cardiovascular morbidity and increased predisposition to infections are of note. In addition, this article addresses further important possible concomitant diseases, i.e., osteoporosis and tumor diseases. A ground rule is to identify comorbidities and treat them just as diligently as the underlying rheumatic disease so that the patient with rheumatism should be accompanied by an interdisciplinary team of internists during each phase of the disease. Effective control of the systemic inflammatory activity may serve to reduce the risk of certain cardiovascular and neoplastic comorbidities.
Similar articles
-
I've been diagnosed with palindromic rheumatism. It seems to come and go a lot. What is it and how can I treat it?Duke Med Health News. 2007 Dec;13(12):12. Duke Med Health News. 2007. PMID: 18290263 No abstract available.
-
Nichtsteroidale Antirheumatika bei rheumatischen Erkrankungen – Was spricht dafür?Dtsch Med Wochenschr. 2017 Nov;142(23):1773-1774. doi: 10.1055/s-0043-112255. Epub 2017 Nov 16. Dtsch Med Wochenschr. 2017. PMID: 29145683 German. No abstract available.
-
Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?Curr Vasc Pharmacol. 2020;18(5):425-430. doi: 10.2174/1570161118666200514222236. Curr Vasc Pharmacol. 2020. PMID: 32410564
-
Complications of Treatments for Pediatric Rheumatic Diseases.Pediatr Clin North Am. 2018 Aug;65(4):827-854. doi: 10.1016/j.pcl.2018.04.008. Pediatr Clin North Am. 2018. PMID: 30031500 Review.
-
Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.Lupus. 2010 May;19(6):675-82. doi: 10.1177/0961203309360539. Epub 2010 Feb 9. Lupus. 2010. PMID: 20144965 Free PMC article. Review.
Cited by
-
[Promotion of physical activity for older patients with rheumatism : Characteristics of inflammatory rheumatic diseases against the background of physical activity recommendations].Z Rheumatol. 2019 Mar;78(2):127-135. doi: 10.1007/s00393-019-0592-0. Z Rheumatol. 2019. PMID: 30694360 Review. German.
-
[Multimorbidity in elderly rheumatic patients part 1].Z Rheumatol. 2013 Aug;72(6):530-8. doi: 10.1007/s00393-012-1115-4. Z Rheumatol. 2013. PMID: 23868730 German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources